StatPearls, LLC

  • Analgesics, Opioid
  • Diarrhea
  • Ileostomy
  • Irritable Bowel Syndrome
  • Loperamide

Loperamide

Loperamide is an FDA-approved synthetic phenylpiperidine opioid with high lipophilicity and is a medication used to treat various forms of diarrhea. Recognized and approved by the FDA, loperamide is an effective intervention for conditions such as traveler’s diarrhea, irritable bowel syndrome associated with chronic diarrhea, and acute nonspecific diarrhea in patients older than 2. Loperamide is also indicated for conditions requiring reducing ileostomy output to manage diverse gastrointestinal challenges. However, this medication requires careful consideration due to its potential for misuse, with reports indicating a concerning increase in morbidity and mortality associated with high doses. This activity explores loperamide’s indications, contraindications, activities, and adverse events, focusing on the essential elements crucial for members of an interprofessional healthcare team involved in managing patients facing toxicity and its related conditions. As the misuse of loperamide gains prevalence, this activity discusses the complexities surrounding its abuse, providing crucial insights for healthcare professionals. Understanding the risks and nuances associated with loperamide is paramount, ensuring a comprehensive approach to patient care that addresses potential complications and sequelae.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 1 creditAMA PRA Category 1 Credit™Up to 1 creditNursingUp to 1 creditPharmacyUp to 1 credit

MOC types

ABS — Accredited CMEUp to 1 pointABPATH — Lifelong LearningUp to 1 pointABA — Lifelong LearningUp to 1 pointABTS — Accredited CMEUp to 1 pointABIM — Medical KnowledgeUp to 1 pointABS — Self-AssessmentUp to 1 pointABP — Lifelong Learning and Self-AssessmentUp to 1 pointABTS — Self-AssessmentUp to 1 point

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Cross-Specialty

Relevant across 11 specialties.

Pricing

Fee varies

This provider typically $49–98

See fees on statpearls.com

Listed by the provider

  • Article / monograph / reference
  • Credit · Up to 1 credit
  • MOC · Up to 1 point
  • Fee varies · this provider typically $49–98
  • Released
    Sep 1, 2026
  • Last day to claim credit
    Sep 1, 2029 3 years left